Delivery Order SPE2DB22D3016-SPE2DB26FAAE5
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $38,377.53 to AmerisourceBergen Drug Corp for the supply of Vyvgart 400 mg/20 ml vials on October 28, 2025, with an ultimate completion date of November 19, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Vyvgart is a specialty pharmaceutical product used in the treatment of autoimmune...
- The Defense Logistics Agency awarded a $42,641.70 firm fixed-price delivery order to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of Vyvgart 400 mg/20 mL vials. The contract, which is non-set-aside and competitively awarded, is scheduled for completion by June 24, 2025, with performance to be fulfilled at AmerisourceBergen's location in Conshohocken, Pennsylvania. This delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $12,792.51 to AmerisourceBergen Drug Corp for VYVGART 400 mg/20 mL vials on September 16, 2025, with completion targeted for October 7, 2025. This firm fixed-price delivery order was competitively awarded without a set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. VYVGART (efgartigimod) is a specialized pharmaceutical product used in the treatment of autoimmune conditions,...
- The U.S. Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Vyvgart 400 mg/20 ml vials. This competitive, firm fixed-price delivery order carries a ceiling value of $8,528.34 and is due for completion by August 29, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This award carries no set-aside designation,...
- The Defense Logistics Agency awarded a delivery order valued at $12,792.51 to AmerisourceBergen Drug Corp for VYVGART 400 mg/20 ml vials on August 26, 2025, with an ultimate completion date of September 17, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The contract represents a child delivery order under AmerisourceBergen's broader Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Vyvgart (efgartigimod) 400 mg/20 mL vials, a specialty pharmaceutical product used in treating autoimmune conditions. This competitively awarded, non-set-aside contract carries a ceiling value of $8,528.34 with firm fixed pricing and a completion date of September 17, 2025. The award is being fulfilled from AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a $12.8K delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Vyvgart 400 mg/20 ml vials. The contract is non-set-aside and competitively awarded with firm fixed pricing, with an ultimate completion date of September 3, 2025. AmerisourceBergen will perform the work at its corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- This delivery order, awarded to AmerisourceBergen Drug Corp on August 28, 2025, is for Vyvgart 400 mg/20 mL vials totaling $17,056.68 under a firm fixed-price arrangement. The contract is funded by the Defense Logistics Agency (DLA), a component of the Department of Defense, and is scheduled for completion by September 19, 2025. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This award represents a non-set-aside, competitively awarded transaction,...
- The Defense Logistics Agency awarded a delivery order valued at $8,528.34 to AmerisourceBergen Drug Corp for VYVGART 400 MG/20 ML vials (20 ML). This is a firm fixed price, non-set-aside contract with performance in Conshohocken, Pennsylvania and an ultimate completion date of August 25, 2025. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999 global pharmaceutical support vehicle running through...
- This is a $12,792.51 firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 400 mg/20 ml vials of the medication Vyvgart. The contract has an ultimate completion date of July 1, 2025 and is not set-aside. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a comprehensive global...
- SPE2DB22D3016Indefinite Delivery Contract
- SPE2DB22D3016-SPE2DB26FAAE5Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $25,585.02 to AmerisourceBergen Drug Corp for Vyvgart 400 mg/20 mL vials on October 20, 2025, with completion expected by November 10, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designations and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Vyvgart is a specialized pharmaceutical product used in the treatment of autoimmune conditions, reflecting the Defense Logistics Agency's Medical Supply Chain's comprehensive procurement of brand-name medications for military healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $999.99 billion vehicle running through December 2026 that serves as a global pharmaceutical support mechanism for military healthcare programs worldwide. As a major pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen Drug Corp maintains an extensive portfolio of federal medical contracts covering a wide spectrum of therapeutic domains, including specialty medications, vaccines, and medical supplies. The company's continued selection for such orders demonstrates its established capability to meet federal procurement requirements and support critical military healthcare operations across multiple service branches and geographic regions.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $25.6k | 10/20/25 |